Platelet and neutrophil to lymphocyte ratios predict survival in patients with resectable colorectal liver metastases

被引:17
作者
Erstad, Derek J. [1 ]
Taylor, Martin S. [2 ]
Qadan, Motaz [1 ]
Axtell, Andrea L. [1 ,3 ]
Fuchs, Bryan C. [1 ]
Berger, David L. [1 ]
Clancy, Thomas E. [4 ]
Tanabe, Kenneth K. [1 ]
Chang, David C. [1 ,3 ]
Ferrone, Cristina R. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Codman Ctr Clin Effectiveness Surg, Boston, MA 02115 USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA
关键词
Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Colorectal; Liver metastasis; Hepatectomy; Overall survival; Prognosis; LONG-TERM SURVIVAL; HEPATIC RESECTION; CANCER; TUMOR; BIOLOGY;
D O I
10.1016/j.amjsurg.2020.05.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The prognostic significance of the platelet (PLR) and neutrophil (NLR) to lymphocyte ratios for patients with resectable colorectal cancer liver metastases (CLM) was evaluated. Methods: Clinicopathologic data from patients who underwent hepatectomy for CLM at two tertiary care hospitals between 1995 and 2017 were collected. Blood counts were evaluated for prognostic significance. Results: 151 patients met inclusion criteria. The median age was 58 years, 44% were female, and 58% had synchronous metastases. Median number of liver metastases was 2, and 59% of patients underwent lobectomy or extended lobectomy. On multivariable analysis, NLR >5 (HR 2.46 [1.08-5.60 CI], p = 0.032), PLR > 220 (HR 2.10 [1.04-4.23 CI], p = 0.037), and greater than 2 liver metastases (HR 2.41 [1.06-5.45 CI], p = 0.035) were associated with reduced overall survival. Conclusions: PLR > 220 and NLR > 5 may have utility as preoperative prognostic markers for overall survival in patients with resectable CLM. (c) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:1579 / 1585
页数:7
相关论文
共 50 条
  • [31] Association of urinary neopterin, neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios with long-term survival of patients with breast cancer
    Melichar, Bohuslav
    Studentova, Hana
    Vitaskova, Denisa
    Sramek, Vlastislav
    Krcmova, Lenka Kujovska
    Peskova, Eliska
    Solichova, Dagmar
    Kalabova, Hana
    Ryska, Ales
    Hruzova, Klara
    Havlik, Roman
    PTERIDINES, 2016, 27 (3-4) : 59 - 65
  • [32] Preoperative to postoperative change in neutrophil-to-lymphocyte ratio predict survival in colorectal cancer patients
    Guo, Dong
    Han, Anqin
    Jing, Wang
    Chen, Dawei
    Jin, Feng
    Li, Minghuan
    Kong, Li
    Yu, Jinming
    FUTURE ONCOLOGY, 2018, 14 (12) : 1187 - 1196
  • [33] Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
    Zhu, Dexiang
    Zhong, Yunshi
    Wei, Ye
    Ye, Lechi
    Lin, Qi
    Ren, Li
    Ye, Qinghai
    Liu, Tianshu
    Xu, Jianmin
    Qin, Xinyu
    PLOS ONE, 2014, 9 (01):
  • [34] Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients
    Losada, B.
    Guerra, J. A.
    Malon, D.
    Jara, C.
    Rodriguez, L.
    Del Barco, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (07) : 855 - 863
  • [35] Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients
    B. Losada
    J. A. Guerra
    D. Malón
    C. Jara
    L. Rodriguez
    S. Del Barco
    Clinical and Translational Oncology, 2019, 21 : 855 - 863
  • [36] Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective
    Zheng, Xia
    Ye, Bin
    Gou, Yudong
    Li, Zixiong
    Chen, Chao
    Liao, Feng
    Liu, Xiufeng
    Qin, Shukui
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (03) : 1261 - 1272
  • [37] Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival
    Jin, Chen
    Li, Chuan
    Peng, Wei
    Wen, Tian-Fu
    Yan, Lv-Nan
    Li, Bo
    Wang, Wen-Tao
    Yang, Jia-Yin
    Xu, Ming-Qing
    MEDICINE, 2017, 96 (33)
  • [38] The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
    Yonekawa, Yoshihiko
    Uehara, Kay
    Mizuno, Takashi
    Aiba, Toshisada
    Ogura, Atsushi
    Mukai, Toshiki
    Yokoyama, Yukihiro
    Ebata, Tomoki
    Kodera, Yasuhiro
    Nagino, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 126 - 134
  • [39] Does preoperative neutrophil to lymphocyte or platelet to lymphocyte ratios have a role in predicting borderline ovarian tumors?
    Khatib, Ghanim
    Soysal, Cenk
    Cetin, Cihan
    Gulec, Umran Kucukgoz
    Guzel, Ahmet Baris
    Keskin, Nadi
    Vardar, Mehmet Ali
    Gumurdulu, Derya
    JOURNAL OF OVARIAN RESEARCH, 2016, 9 : 1 - 6
  • [40] Chemotherapy and repeat resection abrogate the prognostic value of neutrophil lymphocyte ratio in colorectal liver metastases
    Hand, Fiona
    Ryan, Elizabeth J.
    Harrington, Cuan
    Durand, Michael
    Maguire, Donal
    O'Farrelly, Cliona
    Hoti, Emir
    Geoghegan, Justin G.
    HPB, 2020, 22 (05) : 670 - 676